NCT01962935 - Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Chronic Obstructive Pulmonary Disease (COPD).

Interventions

DRUG

AZD4721

Part A - multiple ascending dose, daily; Part B - one dose decided after part A, daily

DRUG

Placebo

Part A - multiple ascending dose daily

DRUG

AZD5069

Part B - one dose decided after part A, twice a day

Trial Locations (1)

Research Site, London